The Research and Development Policy Division, Medical Affairs Bureau, Ministry of Health, Labour and Welfare (MHLW) has issued a notice on the promulgation of the “Act on Safety Assurance of Regenerative Medicine, etc. and Partial Amendment to the Clinical Research Act”. Please refer to the PDF below for details.
For more information, please contact the following address.
Office of Research Promotion for Regenerative Medicine, Research and Development Policy Division, Medical Policy Bureau, Ministry of Health, Labour and Welfare
TEL: 03-5253-1111 (ext. 2587)
TEL: 03-3595-2430 (direct line)
